Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15837535)

  • 1. Wnt signaling in lung cancer.
    Mazieres J; He B; You L; Xu Z; Jablons DM
    Cancer Lett; 2005 May; 222(1):1-10. PubMed ID: 15837535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
    Urakami S; Shiina H; Enokida H; Kawakami T; Tokizane T; Ogishima T; Tanaka Y; Li LC; Ribeiro-Filho LA; Terashima M; Kikuno N; Adachi H; Yoneda T; Kishi H; Shigeno K; Konety BR; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Jan; 12(2):383-91. PubMed ID: 16428476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt signaling activation and WIF-1 silencing in nasopharyngeal cancer cell lines.
    Lin YC; You L; Xu Z; He B; Mikami I; Thung E; Chou J; Kuchenbecker K; Kim J; Raz D; Yang CT; Chen JK; Jablons DM
    Biochem Biophys Res Commun; 2006 Mar; 341(2):635-40. PubMed ID: 16427602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers.
    Taniguchi H; Yamamoto H; Hirata T; Miyamoto N; Oki M; Nosho K; Adachi Y; Endo T; Imai K; Shinomura Y
    Oncogene; 2005 Nov; 24(53):7946-52. PubMed ID: 16007117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer.
    Aguilera O; Fraga MF; Ballestar E; Paz MF; Herranz M; Espada J; García JM; Muñoz A; Esteller M; González-Sancho JM
    Oncogene; 2006 Jul; 25(29):4116-21. PubMed ID: 16491118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt signaling: physiology and pathology.
    Prunier C; Hocevar BA; Howe PH
    Growth Factors; 2004 Sep; 22(3):141-50. PubMed ID: 15518237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer.
    Mazieres J; He B; You L; Xu Z; Lee AY; Mikami I; Reguart N; Rosell R; McCormick F; Jablons DM
    Cancer Res; 2004 Jul; 64(14):4717-20. PubMed ID: 15256437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt signaling in osteosarcoma.
    Lin CH; Ji T; Chen CF; Hoang BH
    Adv Exp Med Biol; 2014; 804():33-45. PubMed ID: 24924167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secreted antagonists of the Wnt signalling pathway.
    Kawano Y; Kypta R
    J Cell Sci; 2003 Jul; 116(Pt 13):2627-34. PubMed ID: 12775774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated expression of Wnt antagonists is a common event in hepatoblastomas.
    Koch A; Waha A; Hartmann W; Hrychyk A; Schüller U; Waha A; Wharton KA; Fuchs SY; von Schweinitz D; Pietsch T
    Clin Cancer Res; 2005 Jun; 11(12):4295-304. PubMed ID: 15958610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in the Wnt signalling pathway in gastrointestinal cancers and their prognostic significance.
    Doucas H; Garcea G; Neal CP; Manson MM; Berry DP
    Eur J Cancer; 2005 Feb; 41(3):365-79. PubMed ID: 15691635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secreted WNT antagonists as tumor suppressors: pro and con.
    Rubin JS; Barshishat-Kupper M; Feroze-Merzoug F; Xi ZF
    Front Biosci; 2006 Sep; 11():2093-105. PubMed ID: 16720296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of Wnt-1 signaling induces apoptosis in human colorectal cancer cells containing downstream mutations.
    He B; Reguart N; You L; Mazieres J; Xu Z; Lee AY; Mikami I; McCormick F; Jablons DM
    Oncogene; 2005 Apr; 24(18):3054-8. PubMed ID: 15735684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wnt signaling and cancer development: therapeutic implication.
    Paul S; Dey A
    Neoplasma; 2008; 55(3):165-76. PubMed ID: 18348648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
    Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
    Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of nitric oxide synthase on multiple drug resistance is related to Wnt signaling in non-small cell lung cancer.
    Li Y; Ma C; Shi X; Wen Z; Li D; Sun M; Ding H
    Oncol Rep; 2014 Oct; 32(4):1703-8. PubMed ID: 25070480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic alterations of CDH1 and APC genes: relationship with activation of Wnt/beta-catenin pathway in invasive ductal carcinoma of breast.
    Prasad CP; Mirza S; Sharma G; Prashad R; DattaGupta S; Rath G; Ralhan R
    Life Sci; 2008 Aug; 83(9-10):318-25. PubMed ID: 18662704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Wnt-er wonderland--the complexity of Wnt signaling in melanoma.
    Weeraratna AT
    Cancer Metastasis Rev; 2005 Jun; 24(2):237-50. PubMed ID: 15986134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of liquid chromatography mass spectrometry analyses to identify LKB1-APC interaction in modulating Wnt/β-catenin pathway of lung cancer cells.
    Jian SF; Hsiao CC; Chen SY; Weng CC; Kuo TL; Wu DC; Hung WC; Cheng KH
    Mol Cancer Res; 2014 Apr; 12(4):622-35. PubMed ID: 24448687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt signaling pathway in mammary gland development and carcinogenesis.
    Turashvili G; Bouchal J; Burkadze G; Kolar Z
    Pathobiology; 2006; 73(5):213-23. PubMed ID: 17314492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.